Glomerulonephritis Market Growth and Trends: Key Insights into Market Opportunities for 2025-2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theGlomerulonephritis Market?
The growing prevalence of kidney disorders is projected to propel the glomerulonephritis market. Kidney disorders are conditions that affect the kidneys’ structure or function, leading to impaired filtration, waste removal, and fluid balance. The rise in kidney disorders is due to factors such as an aging population, increasing chronic disease rates (like diabetes and hypertension), and lifestyle factors. Kidney disorders contribute to glomerulonephritis by triggering immune system dysfunction, chronic inflammation, or structural damage, which in turn impairs kidney function. For example, in December 2024, the Australian Institute of Health and Welfare reported that chronic kidney disease (CKD) mortality rates rose by 4.2% in 2021 and 6.2% in 2022. In the 2021–22 period, CKD was involved in approximately 2 million hospitalizations, accounting for 18% of all hospital admissions in Australia. Therefore, the growing prevalence of kidney disorders will drive the growth of the glomerulonephritis market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21193&type=smp
#What is the Projected CAGR for the Glomerulonephritis Market Size from 2025 to 2034?
The glomerulonephritis market has experienced strong growth, increasing from $11.06 billion in 2024 to $11.64 billion in 2025 at a CAGR of 5.3%. Growth factors include a rising prevalence of kidney disorders, increased cases of infections like post-streptococcal glomerulonephritis, greater investment in R&D, a rise in kidney failure cases, and improved awareness of kidney diseases.
The glomerulonephritis market is expected to grow steadily, reaching $14.14 billion by 2029 at a CAGR of 5.0%. Factors driving this growth include increasing cases of diabetes, an aging population, higher healthcare investments, a growing number of dialysis patients, and a rise in autoimmune diseases. Notable trends include the introduction of new treatments and therapies, advancements in diagnostic technologies, development of novel therapeutics, strategic collaborations between companies, and the adoption of intravenous immunoglobulin therapy.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21193
What Are the Current Market Growth and Trends in theGlomerulonephritis Market That Industry Players Should Watch?
In the glomerulonephritis market, companies are developing non-immunosuppressive treatments to treat kidney diseases without compromising immune function. One such treatment, FILSPARI (sparsentan), was introduced by Travere Therapeutics Inc., a US-based biopharmaceutical company, in September 2024. The FDA-approved drug is designed to treat IgA nephropathy, a kidney disease, and has shown significant promise in slowing the progression of kidney function decline, offering a non-immunosuppressive option for patients who previously had limited treatments.
What Are the Major Market Players Making an Impact on theGlomerulonephritis Market Growth?
Major companies operating in the glomerulonephritis market are Pfizer Inc., F. Hoffmann-La Roche Ltd., AstraZeneca PLC, Novartis International AG, Eli Lilly and Company, Asahi Kasei Medical Co. Ltd., Boehringer Ingelheim International GmbH, DaVita Inc., Biogen Inc., Merit Medical Systems Inc., Apellis Pharmaceuticals Inc., MorphoSys AG, Travere Therapeutics Inc., Vera Therapeutics Inc., Calliditas Therapeutics AB, Omeros Corporation, Otsuka Pharmaceutical Co. Ltd., Aurinia Pharmaceuticals Inc., Alexion Pharmaceuticals Inc., NovelMed Therapeutics Inc.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/glomerulonephritis-global-market-report
How Are the Key Segments of the Glomerulonephritis Market Driving Opportunities and Innovations?
The glomerulonephritis market covered in this report is segmented –
1) By Type: Acute Glomerulonephritis, Chronic Glomerulonephritis
2) By Diagnosis: Urine And Blood Tests, Imaging Tests, Kidney Biopsy, Other Diagnosis
3) By Treatment: Medication, Surgery, Dialysis, Other Treatments
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
5) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Acute Glomerulonephritis: Post-infectious Glomerulonephritis, IgA Nephropathy, Lupus Nephritis, Rapidly Progressive Glomerulonephritis (RPGN), Goodpasture Syndrome
2) By Chronic Glomerulonephritis: Focal Segmental Glomerulosclerosis (FSGS), Membranous Nephropathy, Minimal Change Disease, Alport Syndrome, Diabetic Nephropathy, Hypertensive Nephrosclerosis
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=21193&type=smp
What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theGlomerulonephritis Market?# Market Expansion?
North America was the largest region in the glomerulonephritis market in 2024. The regions covered in the glomerulonephritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Glomerulonephritis Market 2025, By The Business Research Company:
Suture Laparoscopic Forceps Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/suture-laparoscopic-forceps-global-market-report
Electrocautery Enhanced Delivery System Global Market Report 2025
Anemia and Other Blood Disorder Drugs Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
